Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
79.57
+1.28 (1.63%)
Oct 6, 2026, 4:00 PM EDT - Market closed
Monopar Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $101 → $123 | Buy | Maintains | $101 → $123 | +54.58% | Sep 28, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $125 | Buy | Maintains | $125 | +57.09% | Sep 22, 2026 |
| Barclays | Barclays | Buy Maintains $128 → $145 | Buy | Maintains | $128 → $145 | +82.23% | Sep 11, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $115 → $130 | Buy | Reiterates | $115 → $130 | +63.38% | Aug 17, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Downgrades $109 → $119 | Hold | Downgrades | $109 → $119 | +49.55% | Aug 13, 2026 |
| JonesTrading | JonesTrading | Buy Maintains $130 | Buy | Maintains | $130 | +63.38% | Aug 12, 2026 |
| BTIG | BTIG | Buy Maintains $117 → $133 | Buy | Maintains | $117 → $133 | +67.15% | Aug 12, 2026 |
| Lake Street | Lake Street | Buy Maintains $103 | Buy | Maintains | $103 | +29.45% | Jun 30, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.